Eupraxia Pharmaceuticals Insider Trading

TSXEPRXCompany Website
4All Trades
2Significant
2Notable
0Minor
0Cluster
0Repeat
HealthcareSector
BiotechnologyIndustry
$705.7MMarket Cap
7.50 – 12.5952 Week Range
113KAvg. Volume
▼ Filters▲
InsiderSignalTrans DateFile DateSharesPriceValueIncreaseBalance
Montalbano, John
Director
NT19-Aug-2619-Aug-2600,000$0.00USD$000,0000%0,000,000
Pimstone, Simon
Chairman
SI27-Mar-2627-Mar-2600,000$0.00$000,00000%00,000
Freedman, Joseph
Director
NT18-Mar-2618-Mar-2600,000$00.00$000,0000%000,000
Brennan, Paul
Chief Development Officer
SI24-Nov-2526-Nov-2500,000$0.00$000,00000%00,000

Eupraxia Pharmaceuticals (EPRX): 12-Month Stock Price Chart  △ Insider Buys

$█.██
$█.██
$█.██
$█.██
$█.██

Volume (thousands)

Related Companies to Explore

Restart Life SciencesHEALMercanto HoldingsMUSHDoseology SciencesMOODRubicon Organics Inc.ROMJHelix BiopharmaHBPExtendicare Inc.EXE